Sequent Scientific Limited — Important, 26-05-2025: General Updates

Sequent Scientific has announced a board meeting to consider the financial results for the quarter and half-year. The company cleared no-objection letters from BSE and NSE for its composite scheme of amalgamation involving multiple subsidiaries. This consolidation aims to streamline operations and boost synergies in its life sciences businesses. The scheme is pending approvals, with detailed shareholding and financial disclosures to be provided later. No immediate financial impact reported.